Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Exploratory Study to Assess the Biological Activity of ZD6126 in Subjects With Newly Diagnosed Metastatic Renal Cell Carcinoma (Stage IV)

NCT00065572 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT00065572
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00065572 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Exploratory Study to Assess the Biological Activity of ZD6126 in Subjects With Newly Diagnosed Metastatic Renal Cell Carcinoma (Stage IV)
Lead sponsor
AstraZeneca
Phase
Phase 2
Overall status
Suspended
Start date
August 31, 2003
Completion date
February 29, 2004
Enrollment
Not reported
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

carcinoma, renal cell, kidney neoplasms